EU 2019 Approvals: Novel Therapies Make Strong Showing
Firsts Include Ebola Vaccine And Tumor Agnostic Therapy
Bluebird bio’s gene therapy Zynteglo, Akcea’s antisense drug Waylivra and BioMarin’s enzyme substitution therapy Palynziq were among the novel innovative medicines that were approved in Europe in 2019.
